3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Lung Neoplasms
2
Refractory/Relapse Neuroblastoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteoporosis
1
Neuroendocrine Tumors
1
Neoplasms, Squamous Cell
1
Nasopharyngeal Carcinoma
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Melanoma
1
Lymphoma
1
Infertility
1
Hysterectomies for Low- or Intermediate-risk Endometrial Carcinoma
1
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Breast Neoplasms
1
Interventions
Zoledronic Acid
8
Vitamin D
6
Risedronic Acid
6
Calcium
6
Letrozole
4
Cholecalciferol
4
Calcium Carbonate
4
Alendronate
3
parathyroid hormone-related peptide (1-36)
2
bicalutamide
2
Resistance Training
2
Nutrition Assessment
2
Goserelin
2
Estradiol
2
Denosumab
2
Calcium Gluconate
2
Aromatase Inhibitors
2
Absorptiometry, Photon
2
xian ling gu bao
1
romosozumab
1
X-Rays
1
Technetium
1
Raloxifene Hydrochloride
1
Progesterone
1
Parathyroid Hormone-Related Protein
1
Parathyroid Hormone
1
Lysine Acetyltransferase 5
1
Ibandronic Acid
1
Hormone Replacement Therapy
1
Geritol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Osteoporosis
×
Biological Products
×
Clear all
NCT01250314
2012-07-03
OSTEHOM
Assistance Publique - Hôpitaux de Paris
Phase NA
Completed
79 enrolled